Company intelligence
Thryv Therapeutics Inc.
Transforming the treatment of inherited arrhythmias and cardiometabolic diseases.
Biotechnology Research
Montreal, CA
34 employees
Founded 2019
1 public signals
About Thryv Therapeutics Inc.
Thryv Therapeutics Inc. is a clinical-stage biotech pioneering precision medicine approaches to treating genetic arrhythmia syndromes and acquired cardiometabolic diseases through potent and highly selective inhibitors of serum glucocorticoid inducible kinase 1 (SGK1). For more information, please visit www.thryvtrx.com.
Verified activity
Signals from Thryv Therapeutics Inc.
1 published signal